- Home
- IHT vs NERV Comparison
IHT vs NERV Comparison
Compare IHT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- NERV
- Stock Information
- Founded
- IHT 1971
- NERV 2007
- Country
- IHT United States
- NERV United States
- Employees
- IHT N/A
- NERV N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- NERV Health Care
- Exchange
- IHT Nasdaq
- NERV Nasdaq
- Market Cap
- IHT 15.6M
- NERV 18.3M
- IPO Year
- IHT N/A
- NERV 2014
- Fundamental
- Price
- IHT $2.03
- NERV $2.32
- Analyst Decision
- IHT
- NERV Hold
- Analyst Count
- IHT 0
- NERV 1
- Target Price
- IHT N/A
- NERV $5.00
- AVG Volume (30 Days)
- IHT 4.1K
- NERV 25.6K
- Earning Date
- IHT 12-05-2024
- NERV 11-05-2024
- Dividend Yield
- IHT 0.99%
- NERV N/A
- EPS Growth
- IHT N/A
- NERV N/A
- EPS
- IHT N/A
- NERV N/A
- Revenue
- IHT $7,691,676.00
- NERV N/A
- Revenue This Year
- IHT N/A
- NERV N/A
- Revenue Next Year
- IHT N/A
- NERV N/A
- P/E Ratio
- IHT N/A
- NERV N/A
- Revenue Growth
- IHT 6.27
- NERV N/A
- 52 Week Low
- IHT $1.22
- NERV $2.26
- 52 Week High
- IHT $2.25
- NERV $13.49
- Technical
- Relative Strength Index (RSI)
- IHT 58.78
- NERV 39.53
- Support Level
- IHT $2.00
- NERV $2.26
- Resistance Level
- IHT $1.98
- NERV $2.43
- Average True Range (ATR)
- IHT 0.07
- NERV 0.13
- MACD
- IHT 0.01
- NERV -0.01
- Stochastic Oscillator
- IHT 90.74
- NERV 8.77
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.